{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
IO Biotech, Inc.
Is IO Biotech, Inc. technically bullish or bearish?
As of June 17, 2025, the trend is mildly bullish due to positive weekly MACD and KST indicators, but caution is advised due to a bearish monthly KST and mixed longer-term signals.
What does IO Biotech, Inc. do?
IO Biotech, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $22 million and a market cap of $86.96 million. The company has no dividend yield and negative financial metrics, including a debt equity ratio of -1.38 and a return on equity of -372.63%.
How big is IO Biotech, Inc.?
As of Jun 18, IO Biotech, Inc. has a market capitalization of 86.96 million, with net sales of 0.00 million and a net profit of -98.46 million over the latest four quarters. Shareholder's funds are at 47.02 million, and total assets are 67.70 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
